Title

Effects of CoEnzyme Q 10 Supplementation on Women Suffering from Episodic Migraines

Document Type

Poster

Campus where you would like to present

Ellensburg

Event Website

https://digitalcommons.cwu.edu/source

Start Date

16-5-2021

End Date

22-5-2021

Keywords

supplements, migraine, Coenzyme Q 10

Abstract

Migraine headaches effect a large portion of the human population, disrupting productivity and quality of life. Limited research suggests potential preventative properties of consuming the antioxidant, Coenzyme Q 10 (CoQ10); which could lower various migraine characteristics such as frequency, severity, and duration. For this randomized controlled trial (RCT), 70 cis-female subjects (ages 18 – 50 years) will be recruited and randomized to either a CoQ10 or a placebo supplement for three months. This trial will collect baseline and post data to see the effects of CoQ10 consumption along with regular prescribed medications on duration, frequency, and severity of migraine headaches. All data will be collected through a virtual daily journal log. Daily journal logs include a numeric rating scale (NRS) to assess pain severity, hours and minutes to record durations, and frequency is based on number of migraines recorded. We hypothesize that young to middle aged women who suffer with episodic migraines will decrease in the severity, duration, and frequency when consuming the antioxidant, CoQ10.

Faculty Mentor(s)

Nicole Stendell-Hollis

Department/Program

Health Sciences

Additional Mentoring Department

https://cwu.studentopportunitycenter.com/effects-of-coenzyme-q-10-supplementation-on-women-suffering-from-episodic-migraines/

Share

COinS
 
May 16th, 12:00 PM May 22nd, 12:00 PM

Effects of CoEnzyme Q 10 Supplementation on Women Suffering from Episodic Migraines

Ellensburg

Migraine headaches effect a large portion of the human population, disrupting productivity and quality of life. Limited research suggests potential preventative properties of consuming the antioxidant, Coenzyme Q 10 (CoQ10); which could lower various migraine characteristics such as frequency, severity, and duration. For this randomized controlled trial (RCT), 70 cis-female subjects (ages 18 – 50 years) will be recruited and randomized to either a CoQ10 or a placebo supplement for three months. This trial will collect baseline and post data to see the effects of CoQ10 consumption along with regular prescribed medications on duration, frequency, and severity of migraine headaches. All data will be collected through a virtual daily journal log. Daily journal logs include a numeric rating scale (NRS) to assess pain severity, hours and minutes to record durations, and frequency is based on number of migraines recorded. We hypothesize that young to middle aged women who suffer with episodic migraines will decrease in the severity, duration, and frequency when consuming the antioxidant, CoQ10.

https://digitalcommons.cwu.edu/source/2021/COTS/48